Micki Klearman
- Rheumatology top 0.2%
- Rheumatoid Arthritis Research and Therapies 14
- Systemic Lupus Erythematosus Research 12
- Urticaria and Related Conditions 6
- Otitis Media and Relapsing Polychondritis 5
- Genetics top 2%
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 10
- Hematology top 2%
- Autoimmune and Inflammatory Disorders Research 5
-
- Vasculitis and related conditions 14
- Immunology top 5%
-
- Renal Diseases and Glomerulopathies 3
- Co-authors
- Katie TuckwellDavid MusselmanNeil CollinsonJohn H. StoneCem GabaySophie DimonacoArthur KavanaughBhaskar Dasgupta
- Cited by
- RheumatologyGeneticsHematology
- Journals
- Annals of the Rheumatic Diseases (12 papers)Seminars in Arthritis and Rheumatism (5 papers)Arthritis & Rheumatology (4 papers)
- Partner nations
- United StatesUnited KingdomSwitzerland
In The Last Decade
Micki Klearman
29 papers receiving 2.6k citations
Hit Papers
Peers
Comparison fields: 5 of 80
- Rheumatology 1.8k
- Genetics 587
- Hematology 455
- Pulmonary and Respiratory Medicine 1.1k
- Immunology 598
Countries citing papers authored by Micki Klearman
This map shows the geographic impact of Micki Klearman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Micki Klearman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Micki Klearman more than expected).
Fields of papers citing papers by Micki Klearman
This network shows the impact of papers produced by Micki Klearman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Micki Klearman. The network helps show where Micki Klearman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Micki Klearman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 32 | |
| 2 | 2019 | 168 | |
| 3 | 2019 | 2 | |
| 4 | 2019 | 66 | |
| 5 | 2018 | 35 | |
| 6 | Trial of Tocilizumab in Giant-Cell Arteritisbreakdown → | 2017 | 815 |
| 7 | 2017 | 158 | |
| 8 | 2017 | 2 | |
| 9 | 2016 | 78 | |
| 10 | 2016 | 81 | |
| 11 | Baseline data on patients enrolled in a randomized, double-masked trial of tocilizumab in giant cell arteritis | 2016 | 1 |
| 12 | 2016 | 47 | |
| 13 | 2016 | 54 | |
| 14 | 2015 | 11 | |
| 15 | 2015 | 117 | |
| 16 | 2014 | 265 | |
| 17 | 2014 | 81 | |
| 18 | Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trialbreakdown → | 2013 | 502 |
| 19 | 2013 | 7 | |
| 20 | 2012 | 1 |
About Micki Klearman
Micki Klearman is a scholar working on Rheumatology, Genetics and Hematology, having authored 31 papers that have together received 2.7k indexed citations. Recurring topics across this work include Vasculitis and related conditions (14 papers), Rheumatoid Arthritis Research and Therapies (14 papers), Systemic Lupus Erythematosus Research (12 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (10 papers), Urticaria and Related Conditions (6 papers), Otitis Media and Relapsing Polychondritis (5 papers), Autoimmune and Inflammatory Disorders Research (5 papers) and Renal Diseases and Glomerulopathies (3 papers). The work is most often cited by research in Rheumatology (1.8k citations), Genetics (587 citations) and Hematology (455 citations). Micki Klearman has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Katie Tuckwell, David Musselman, Neil Collinson, John H. Stone, Cem Gabay, Sophie Dimonaco, Arthur Kavanaugh, Bhaskar Dasgupta, Jürgen Rech and María C. Cid. Their work appears in journals such as Annals of the Rheumatic Diseases, Seminars in Arthritis and Rheumatism, Arthritis & Rheumatology, Arthritis Research & Therapy and International Journal of Rheumatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.